David Healy follows his widely praised study, The Antidepressant Era, with an even more ambitious and dramatic story: the discovery and development of antipsychotic medication. Healy argues that the discovery of chlorpromazine (more generally known as Thorazine) is as significant in the history of medicine as the discovery of penicillin, reminding readers of the worldwide prevalence of insanity within living memory.
But Healy tells not of the triumph of science but of a stream of fruitful accidents, of technological discovery leading neuroscientific research, of fierce professional competition and the backlash of the antipsychiatry movement of the 1960s. A chemical treatment was developed for one purpose, and as long as some theoretical rationale could be found, doctors administered it to the insane patients in their care to see if it would help. Sometimes it did, dramatically. Why these treatments worked, Healy argues provocatively, was, and often still is, a mystery. Nonetheless, such discoveries made and unmade academic reputations and inspired intense politicking for the Nobel Prize.
Once pharmaceutical companies recognized the commercial potential of antipsychotic medications, financial as well as clinical pressures drove the development of ever more aggressively marketed medications. With verve and immense learning, Healy tells a story with surprising implications in a book that will become the leading scholarly work on its compelling subject.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
David Healy is Reader in Psychological Medicine at the University of Wales College of Medicine.Review:
[T]his sweeping history of medicine used to treat mental illness takes on the psychiatric and medical establishment...Healy does groundbreaking work...The Creation of Psychopharmacology details how psychiatric medication intersects with academic squabbles and popular culture. (Janice Paskey Chronicle of Higher Education 2002-01-25)
David Healy is a respected historian of psychiatry who has written a book that should spark a major debate. He identifies current trends towards the abandonment of independent research into treatments for mental illness, the demand for Randomised Control Trials as the only acceptable measure of whether a treatment works, and the chilling control pharmaceutical companies now exert over psychiatry...This is an important and thought-provoking book...Healy's warning that, without a debate, we may be moving into an era when cosmetic psychiatry will be the new liposuction is worth heeding. (Julie Wheelwright The Independent 2002-05-07)
This book is a good place to start if you want to get an overview of the role of drugs in the treatment of mental illness...[Healy] capture[s] an important current dilemma. (Richard Restak Washington Times 2002-03-25)
Psychiatrists and historians owe a debt to David Healy. Over the years he has conducted interviews with all the leading figures in psychopharmacology...Drawing on these interviews and his wide reading of the scholarly literature, Healy has now constructed a subtle and compelling narrative of the development of psychotropic drugs...Healy ambitiously relates the emergence of drugs to the wider culture and shows how the two have interacted...[He] has written a highly stimulating and original book, which is brimful of ideas and deserves to be read and debated throughout the psychiatric community and beyond. (Allan Beveridge British Journal of Psychiatry 2003-02-01)
[N]o one has described it more thoroughly, or elucidated the critical intersections between psychiatry and the pharmaceutical industry more clearly. (Morgan T. Sammons Contemporary Psychology 2004-04-01)
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Buchbeschreibung Harvard Univ Pr, 2002. Hardcover. Buchzustand: Fine. Zustand des Schutzumschlags: Fine. 1st Edition. Clean With No Remarks Or Highlights Inside. 469 Pages With The Index. Hardcover With A Fine Dust Jacket.We ship from the USA and Canada. Artikel-Nr. 032472